Letter to the editor: “Safety of nonsteroidal anti-inflammatory drugs in copperhead snakebite patients” by Pham and Mullins, Clin Toxicol 2018 May 18

"Letter to the editor: “Safety of nonsteroidal anti-inflammatory drugs in copperhead snakebite patients” by Pham and Mullins, Clin Toxicol 2018 May 18." Clinical Toxicology, 57(2), pp. 144–145

Acknowledgments

The authors thank Suzanne Ward (BTG International) and Chip Perry (Rare Disease Therapeutics) for access to unpublished study data for this analysis.

Disclosure statement

This letter and the analyses contained were prepared without funding support. The referenced clinical trials were supported by BTG International, Inc. and Instituto Bioclon, as stated in the respective trial publications. Denver Health and Duke University have received research grant and other funding from BTG International, and Denver Health has received research funding from Instituto Bioclon. Neither author has received funds personally, nor has other interests to declare.